PRESS RELEASE published on 03/07/2025 at 14:00, 1 year 3 months ago BIO-Europe Spring 2025: Partnering is Surging—All Roads Lead to Milan for Biopharma’s Premier Springtime Event EBD Group announces BIO-Europe Spring 2025 in Milan, the premier springtime event for the biopharma industry, featuring high-impact partnering meetings and top pharma presentations Biopharma EBD Group Milan Partnering BIO-Europe Spring 2025
BRIEF published on 02/13/2025 at 16:35, 1 year 4 months ago BIO-Europe Spring® 2025 ouvre la voie à l'innovation à Milan Partenariats En Biotechnologie Milan Innovation BIO-Europe Printemps 2025 Conférence Sur Les Sciences De La Vie Plateforme PartneringONE
BRIEF published on 02/13/2025 at 16:35, 1 year 4 months ago BIO-Europe Spring® 2025 Sets Stage for Innovation in Milan Biotech Partnerships BIO-Europe Spring 2025 Milan Innovation Life Sciences Conference PartneringONE Platform
PRESS RELEASE published on 02/13/2025 at 16:30, 1 year 4 months ago BIO-Europe Spring® 2025 Propels the New Wave of Innovation in Milan BIO-Europe Spring 2025 in Milan to drive innovation with over 3,700 stakeholders and 20,000 partnering meetings. Registration open until March 14, 2025 Innovation Partnerships Milan Registration BIO-Europe Spring 2025
BRIEF published on 11/27/2024 at 11:39, 1 year 7 months ago Biotech Showcase™ célèbre 17 ans d'innovation Investissement Innovation Sciences De La Vie Mise En Réseau Vitrine Biotechnologique
BRIEF published on 11/27/2024 at 11:39, 1 year 7 months ago Biotech Showcase™ Celebrates 17 Years of Innovation Innovation Biotech Showcase Life Sciences Investment Networking
PRESS RELEASE published on 11/27/2024 at 11:34, 1 year 7 months ago Biotech Showcase™ marking 17 years of innovation and opportunity Biotech Showcase™ marking 17 years of innovation and opportunity to be held in San Francisco, January 13-15, 2025, featuring digital partnering and expertly curated program connecting industry leaders and investors Innovation Biotech Showcase Partnership Biopharma San Francisco
BRIEF published on 10/08/2024 at 14:05, 1 year 8 months ago Global Biopharma Community Gears Up for BIO-Europe 2024 Biopharma Partnerships BIO-Europe 2024 Life Science Innovation Conference Panels Cardiometabolic Therapies
BRIEF published on 10/08/2024 at 14:05, 1 year 8 months ago La communauté biopharmaceutique mondiale se prépare pour BIO-Europe 2024 Partenariats Biopharmaceutiques BIO-Europe 2024 Innovation Dans Les Sciences De La Vie Panels De Conférence Thérapies Cardiométaboliques
PRESS RELEASE published on 10/08/2024 at 14:00, 1 year 8 months ago The global biopharma community is now actively partnering for BIO-Europe® 2024 Global biopharma community actively partnering for BIO-Europe® 2024, leading industry conference in Stockholm, Sweden. Event features workshops, panels, networking opportunities. Celebrating 30 yrs of partnerships & innovation Innovation Conference Biopharma Partnering BIO-Europe
Published on 06/29/2026 at 22:01, 1 hour 41 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 8 hours 42 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 15:00, 8 hours 42 minutes ago Vox Royalty Highlights Significant Gold Offtake-Stream Exposure to Los Filos Following Key Milestone Announcement
Published on 06/29/2026 at 14:30, 9 hours 12 minutes ago Unusual Machines Added to Russell 2000(R) Index
Published on 06/29/2026 at 14:30, 9 hours 12 minutes ago Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web
Published on 06/29/2026 at 22:47, 55 minutes ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 1 hour 37 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 1 hour 37 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 3 hours 12 minutes ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 3 hours 42 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 5 hours 12 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 5 hours 12 minutes ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 5 hours 57 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros
Published on 06/29/2026 at 17:45, 5 hours 57 minutes ago Déclaration hebdomadaire de rachat d'actions